Rare Disease Week 2026

TNA UK | 23 February 2026 | Aneeta Prem | London

Rare Disease Week 2026: Why Trigeminal Neuralgia Must Be Believed. Rare Disease Week (23 to 27 February) and Rare Disease Day (28 February 2026) are meant to do more than raise awareness. They are a test of whether systems respond fairly when an illness is severe, unfamiliar, and easy to misroute.

Trigeminal neuralgia (TN) sits firmly in that space.

Rare disease is not rare. Being believed is.

What does a rare disease mean in the UK?

In the UK and across Europe, a rare disease is generally defined as a condition affecting fewer than 1 in 2,000 people. Rare diseases are individually uncommon, but collectively they affect millions. UK rare disease policy and UK rare disease coordination bodies consistently reference that more than 3.5 million people in the UK live with a rare condition.

That definition matters because “rare” changes how systems behave. Unfamiliar conditions are more likely to be delayed, doubted, and pushed between services. When that happens, the person pays in lost time, lost function, and preventable deterioration.

What trigeminal neuralgia looks like

Trigeminal neuralgia is a neurological pain condition affecting the trigeminal nerve, which carries sensation from the face to the brain. Many people experience sudden attacks of severe, electric shock-like facial pain.

For some, the hardest part is not only the intensity. It is the triggers. Pain can be set off by everyday actions that cannot be avoided: eating, speaking, brushing teeth, washing the face, light touch, cold air, and even a breeze.

This is why belief matters. When pain is tied to basic life functions, delay is not merely inconvenient. It can affect nutrition, sleep, communication, work, relationships, mental health, and the ability to plan a day without fear of the next trigger.

Why TN fits the rare disease framework

Trigeminal neuralgia is recognised within established rare disease classification systems. In the European rare disease taxonomy, it is described as a rare acquired peripheral neuropathy characterised by paroxysmal electric shock-like facial pain.

The problem is that TN can be episodic. People may appear well between attacks. Imaging does not always deliver instant clarity. In those gaps, patients are often treated as uncertain rather than urgent. That is where misrouting begins and where months, and sometimes years, can be lost.

Rare disease framing is not a label. It is a prompt for earlier escalation and cleaner pathways.

TN is not the only severe facial pain condition

A further reason patients get bounced is that “facial pain” is sometimes treated as one broad category. Clinically, it is not.

TN sits alongside other trigeminal and facial pain disorders that can look similar to non-specialists, but may require different decision-making and routes of care. These include:

Classical trigeminal neuralgia is often associated with neurovascular compression and clear trigger-linked pain attacks.
Secondary trigeminal neuralgia, where an underlying neurological cause is present, including multiple sclerosis or other structural lesions affecting the trigeminal nerve.
Idiopathic trigeminal neuralgia, where the clinical picture fits TN but no clear structural cause is identified. “Idiopathic” does not mean mild. It reflects diagnostic limits.
Painful trigeminal neuropathy involves ongoing pain from trigeminal nerve injury, which may follow trauma, infection, surgery, or dental procedures. Pain may be more constant or burning, sometimes with sharp flares.
Post-herpetic trigeminal neuropathy, where facial pain persists after shingles affecting the trigeminal nerve.
Persistent idiopathic facial pain (PIFP), previously known as atypical facial pain, is often continuous and disabling, and too easily dismissed because it does not follow a neat pattern.
SUNCT and SUNA, rare short-lasting unilateral neuralgiform headache disorders with cranial autonomic symptoms, are defined and classified in the International Classification of Headache Disorders.

The practical point is simple. These conditions are not interchangeable. When they are treated as interchangeable, people are delayed, mismanaged, and left to cope on their own.

The belief gap is a systems problem

Belief does not mean abandoning clinical rigour. It means applying it properly.

Belief means listening carefully the first time, recording symptoms accurately, recognising severity, and escalating when the first explanation does not fit. It means treating disabling facial pain as urgent, even when a definitive cause is not yet confirmed.

When severe pain is doubted or minimised, the consequences are predictable: repeated reassurances instead of action, hand-offs between services, inconsistent pain management access, inappropriate detours, and people falling out of work or education before the right pathway even begins.

What equity would look like for trigeminal neuralgia

Rare Disease Week 2026 is strongly centred around equity for individuals with rare conditions. For trigeminal neuralgia, equity is not a slogan. It shows up in whether:

Referral routes are clear and timely
People can access clinicians with the relevant expertise
Pain management is available without prolonged delay
Reasonable adjustments are offered early at work and in education
People are treated as credible before their life narrows

Equity also means reducing the burden on patients to repeatedly justify, retell, and prove their pain.

What needs to change

For trigeminal neuralgia and related facial pain conditions, improvement is practical and achievable. It requires:

earlier recognition and escalation when symptoms suggest a trigeminal disorder
clearer referral routes to appropriate specialist services
timely access to pain management
better understanding of the spectrum of trigeminal and facial pain disorders, so patients are not misrouted or dismissed

Rare disease frameworks exist because delay is foreseeable and preventable.

What you can do during Rare Disease Week

If you want Rare Disease Week 2026 to matter, keep it practical.

Share one accurate sentence about TN.
Example: “Trigeminal neuralgia can cause electric shock-like facial pain triggered by everyday actions. Belief and early escalation matter.”
If you are an employer or educator, ask what adjustment would stop someone from falling out of work or study while they are trying to access care.
If you work in healthcare, ask what might be missed when the obvious explanation does not fit, and who owns the next step.
If you commission services, ask where delay has become normalised and what that costs in human and economic terms.

TNA UK: support beyond awareness

TNA UK exists to ensure people with trigeminal neuralgia and facial pain are not left to navigate this alone. We advocate for clearer pathways, timely access to pain management, and specialist care that reflects the severity of facial pain conditions. We also provide practical support and signposting for patients and families.

Rare Disease Week is a moment. Belief must be the standard.

Rare disease is not rare. Being believed is.

FAQs

When is Rare Disease Day 2026?

Rare Disease Day 2026 takes place on 28 February 2026, the last day of February.

What is the UK definition of a rare disease?

A rare disease is generally defined as affecting fewer than 1 in 2,000 people.

Is trigeminal neuralgia classed as rare?

Trigeminal neuralgia is recognised within established rare disease classification systems and is treated within rare disease frameworks.

What are SUNCT and SUNA?

SUNCT and SUNA are rare headache disorders involving short-lasting unilateral neuralgiform attacks with cranial autonomic symptoms. They are defined in the International Classification of Headache Disorders (ICHD-3).

Rare Disease Day 2025

Sources

UK Rare Diseases Framework (UK Government)
Genetic Alliance UK: Rare Disease Day 2026
NHS England Genomics Education Programme: rare disease definition
Orphanet: trigeminal neuralgia classification
International Classification of Headache Disorders (ICHD-3): SUNCT and SUNA definitions